Tootip...i am struggling to see anything positive with this company. Very little cash available to them. Trial sites (yes. Locations for the trial) STILL aren't lined up. This is a new one for me. Have invested in biotechs quite a few times. All of them could at least get the freakin places finalized before they run out of money. The pause was crap, but admit it. Enrollments sucked long before that. Europe??? Hello? What the hell is going on there? They need 50 people. 15 in 3 years?
Ceo killed us. Killed us!
SHC Price at posting:
2.5¢ Sentiment: None Disclosure: Held
